A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
Clinical trial NCT07759128 · RECRUITING
Trial details
- NCT number
- NCT07759128
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-28
- Primary completion
- 2028-12-06
- Enrollment
- 576
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.